Senior insider sale
SVP, Diagnostics, clonoSEQ at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$389.7K
21K shares
What this filing means
BOBULSKY SUSAN plans to sell 21K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $389.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001950047-26-006508
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
21K
Shares to sell
$389.7K
Approx. market value
5K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Previously Exercised Stock Options
Cash
1/25/2022
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/25/2022 | Previously Exercised Stock Options Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5K
Market value
$95.0K
6/11/2026
—Completed
Units to sell
11K
Market value
$198.0K
6/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5K
Market value
$96.7K
6/25/2026
Total
Units
21K
Value
$389.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/11/2026 | 5K | $95.0K | — | Completed |
6/4/2026 | 11K | $198.0K | — | Completed |
| Planned — Approximate Date | ||||
6/25/2026 | 5K | $96.7K | NASDAQ | Planned |
| Total | 21K | $389.7K | ||